- Blood Sugar
- Clinical Studies
- Complementary Medicine
- Diabetes and Men
- Erectile Dysfunction
- Food and Nutrition
- Insulin Pumps
- Meters and Test Strips
- Product Recalls
- Type 1
- Type 2
- Weight Loss Surgery
April 23, 2015 (MedicalXpress) — A drug approved to treat type 2 diabetes could prove to be a powerful new treatment option for non-alcoholic steatohepatitis (NASH), according to research presented today at The International Liver Congress 2015. Results from a randomised controlled trial showed liraglutide met the primary endpoint of histological clearance of NASH, and a reduction in the progression of fibrosis. The research was supported by the Wellcome Trust and the NIHR.<
April 23, 2015 (Medical Xpress) - Suzanne V. Arnold, M.D., M.H.A., from Saint Luke's Mid America Heart Institute in Kansas City, Mo., and colleagues reported on the incidence of new DM and its recognition among patients with AMI. Data were included for patients in a 24-site U.S. AMI registry from 2005 to 2008.
The researchers found that 10 percent of the 2,854 AMI patients without known DM on admission met criteria for previously unknown DM, defined by a core laboratory glycosylated hem
April 24, 2015 (HealthDay) - In a small, preliminary study, high-dose insulin capsules safely induced what appears to be a protective immune response in children at high risk of developing type 1 diabetes. The study findings were published in the Journal of the American Medical Association, a theme issue on child health.
For the study, the researchers recruited 25 children aged 2 to 7 years. All had a strong family history of type 1 diabetes and were considered ge
April 23, 2015 (Health24) - A growing number of American children and teens with type 1 diabetes are experiencing a life-threatening complication at the time of their diagnosis, a new study finds.
Researchers say a lack of insurance may mean some children are getting diagnosed with type 1 late in its development, when serious complications can arise.
The complication is called diabetic ketoacidosis (DKA), which involves dangerously high blood sugar and substances in the blood cal
April 23, 2015 (Physician's Briefing) - Calorie restriction (CR) and exercise (EX)-induced weight loss have additive benefits on glucoregulation, according to a study published online April 15 in Diabetes Care.
Edward P. Weiss, Ph.D., from Saint Louis University, and colleagues examined whether CR has additive benefits to those from EX-induced weight loss. Fifty-two sedentary overweight men and women (45 to 65 years of age) were randomized to undergo 6 to 8 percent weight loss by CR, EX, or CR and EX (CREX). Du
One in Ten AMI Patients Have Unrecognized Incident Diabetes
Two New LDL Cholesterol Drugs May Have Big Impact on Heart Disease
COBA Conference Steers Forward in the Fight Against Childhood Obesity
Google Secures Patent for Glucose-Sensing Contact Lens
Medtronic to Use GlucoSitter Artificial Pancreas Software in Future Insulin Pumps - A Big Deal!